Sept 22 (Reuters) – Dialybrid: * DIALYBRID SECURES €15 MILLION SERIES A ROUND AND ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN IMPLANT OF NOVEL SILKOTHANE® ARTERIOVENOUS GRAFT FOR VASCULAR ACCESS IN
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Anthropic, OpenAI call for Australia to relax ban on training of AI models
SYDNEY, Sept 22 (Reuters) - Top AI companies OpenAI and Anthropic urged Australia to rethink…
Oil prices climb ahead of potential US-Iran talks
By Anushree Mukherjee LONDON, Sept 22 (Reuters) - Oil prices gained on Tuesday after declining…
Kolkata (West Bengal) [India], September 21: FORCAS STUDIO LIMITED (NSE: FORCAS) India’s apparel industry is…
